Want to see BEAM full AI Analyst Report?
Beam Therapeutics (BEAM) Ownership Overview
3.36% Insiders
21.76% Mutual Funds
43.63% Other Institutional Investors
29.20% ETFs
2.05% Public Companies and Individual Investors
The ownership structure of Beam Therapeutics (BEAM) stock is a mix of institutional, retail, and individual investors. Approximately 94.59% of the company’s stock is owned by Institutional Investors, 3.36% is owned by Insiders, and 2.05% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jun 29, 2026 | xxxxxxxxxxxxx | $10039492 | |
Oct 29, 2025 | xxxxxxxxxxxxx | $12246 | |
Aug 01, 2025 | xxxxxxxxxxxxx | $991667 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $351313111 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $351260464 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $5271552 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,236,396 | Institution | 9.91% | 297,060,212 | |
| 10,234,862 | Institution | 9.91% | 297,015,695 | |
| 9,131,479 | Institution | 8.84% | 264,995,521 | |
| 8,755,873 | Institution | 8.48% | 254,095,434 | |
| 7,680,204 | Institution | 7.44% | 222,879,520 | |
| 5,027,219 | Institution | 4.87% | 145,889,895 | |
| 4,695,065 | Institution | 4.55% | 136,250,786 | |
| 4,046,719 | Institution | 3.92% | 117,435,785 | |
| 1,695,828 | Insider | 1.64% | 49,212,929 | |
| 1,150,205 | Insider | 1.11% | 33,378,949 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,680,204 | Institution | 7.44% | 222,879,520 | |
| 5,027,219 | Institution | 4.87% | 145,889,895 | |
| 1,137,582 | Institution | 1.10% | 33,012,630 | |
| 1,093,992 | Institution | 1.06% | 31,747,648 | |
| 1,033,415 | Institution | 1.00% | 29,989,703 | |
| 993,750 | Institution | 0.96% | 28,838,625 | |
| 794,221 | Institution | 0.77% | 23,048,293 | |
| 660,314 | Institution | 0.64% | 19,162,312 | |
| 569,078 | Institution | 0.55% | 16,514,644 | |
| 436,666 | Institution | 0.42% | 12,672,047 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,818,507 | Institution | 5.63% | 168,853,073 | |
| 3,553,962 | Institution | 3.44% | 104,593,102 | |
| 3,287,274 | Institution | 3.18% | 83,891,232 | |
| 2,517,551 | Institution | 2.44% | 73,059,330 | |
| 2,436,176 | Institution | 2.36% | 70,697,828 | |
| 2,361,252 | Institution | 2.29% | 81,038,169 | |
| 1,371,013 | Institution | 1.33% | 34,988,252 | |
| 1,148,877 | Institution | 1.11% | 29,319,341 | |
| 831,754 | Institution | 0.81% | 24,137,501 | |
| 701,747 | Institution | 0.68% | 20,364,698 |
FAQ
Who Owns Beam Therapeutics (BEAM)?
According to the latest TipRanks data, approximately 43.63% of the company's stock is held by institutional investors, 3.36% is held by insiders, and 2.05% is held by retail investors.
What percentage of Beam Therapeutics (BEAM) stock is held by institutional investors?
According to the latest TipRanks data, approximately 43.63% of Beam Therapeutics (BEAM) stock is held by institutional investors.
What percentage of Beam Therapeutics (BEAM) stock is held by retail investors?
According to the latest TipRanks data, approximately 2.05% of Beam Therapeutics (BEAM) stock is held by retail investors.
Who owns the most shares of Beam Therapeutics (BEAM)?
Andrew J.M. Spokes owns the most shares of Beam Therapeutics (BEAM).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.